Hospital Adoption Zeta Surgical has announced the first commercial deployment of its FDA-cleared Zeta TMS Navigation System and has an active hospital partnership with Brigham and Women's Hospital. This signals a credible path to scale with major academic medical centers and neurosurgery departments; develop targeted outreach, case studies, and procurement-ready materials for neurosurgery, interventional radiology, and perioperative leadership.

Defense Opportunities An ongoing collaboration with NRx Defense Systems to develop Combined Neuroplastic Therapy including D-Cycloserine (NRX-101) and Robotic-enabled Transcranial Magnetic Stimulation for military and first-responder settings creates a defense-oriented sales channel. Target DoD, VA medical centers, and defense contractors, and propose pilots at military medical facilities or field hospital pilots.

Robotics TMS Expansion The Zeta TMS Navigation System complements real-time stereotactic neurosurgical navigation and robotics; this creates cross-sell opportunities into hospitals performing neurosurgery, TMS therapy, and neurorehabilitation. Offer integrated training, service, and maintenance packages to accelerate adoption.

VC Credibility Backed by Y Combinator and Innospark Ventures, Zeta Surgical carries credibility and access to expansive medtech networks that can open doors to large hospital systems, distributors, and research partnerships. Leverage investor connections for co-marketing and pilot programs.

IT Integration The tech stack leveraging AWS, Google Maps, Webflow and Cloudflare security indicates readiness for IT and data integrations with hospital PACS and EHR systems. Position offerings to IT and cybersecurity leaders by proposing standards-based interfaces, data security, and interoperability as procurement differentiators.